http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2024, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Wed, 24 Apr 2024 06:00:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Press+Releases/Tryp+Therapeutics+Provides+Update+on+Plan+of+Arrangement+With+Exopharm+Limited+and+Announces+Voluntary+Trading+Halt/23105710.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Tryp+Therapeutics+Provides+Update+on+Plan+of+Arrangement+With+Exopharm+Limited+and+Announces+Voluntary+Trading+Halt/23105710.html for the full story. http://www.streetinsider.com/Press+Releases/Tryp+Therapeutics+Provides+Update+on+Plan+of+Arrangement+With+Exopharm+Limited+and+Announces+Voluntary+Trading+Halt/23105710.html Wed, 24 Apr 2024 06:00:00 -0400 TRYPF http://www.streetinsider.com/Accesswire/Tryp+Therapeutics+Provides+Update+on+Plan+of+Arrangement+With+Exopharm+Limited+and+Announces+Voluntary+Trading+Halt/23105710.html Visit StreetInsider.com at http://www.streetinsider.com/Accesswire/Tryp+Therapeutics+Provides+Update+on+Plan+of+Arrangement+With+Exopharm+Limited+and+Announces+Voluntary+Trading+Halt/23105710.html for the full story. http://www.streetinsider.com/Accesswire/Tryp+Therapeutics+Provides+Update+on+Plan+of+Arrangement+With+Exopharm+Limited+and+Announces+Voluntary+Trading+Halt/23105710.html Wed, 24 Apr 2024 06:00:00 -0400 TRYPF http://www.streetinsider.com/Press+Releases/Tryp+Therapeutics+Announces+99.92%25+Votes+Cast+by+Shareholders+in+Favor+of+Arrangement+Agreement+at+Annual+General+and+Special+Meeting+of+Securityholders%2C+and+Receipt+of+Final+Order/22916145.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Tryp+Therapeutics+Announces+99.92%25+Votes+Cast+by+Shareholders+in+Favor+of+Arrangement+Agreement+at+Annual+General+and+Special+Meeting+of+Securityholders%2C+and+Receipt+of+Final+Order/22916145.html for the full story. http://www.streetinsider.com/Press+Releases/Tryp+Therapeutics+Announces+99.92%25+Votes+Cast+by+Shareholders+in+Favor+of+Arrangement+Agreement+at+Annual+General+and+Special+Meeting+of+Securityholders%2C+and+Receipt+of+Final+Order/22916145.html Tue, 12 Mar 2024 06:00:00 -0400 TRYPF http://www.streetinsider.com/Accesswire/Tryp+Therapeutics+Announces+99.92%25+Votes+Cast+by+Shareholders+in+Favor+of+Arrangement+Agreement+at+Annual+General+and+Special+Meeting+of+Securityholders%2C+and+Receipt+of+Final+Order/22916145.html Visit StreetInsider.com at http://www.streetinsider.com/Accesswire/Tryp+Therapeutics+Announces+99.92%25+Votes+Cast+by+Shareholders+in+Favor+of+Arrangement+Agreement+at+Annual+General+and+Special+Meeting+of+Securityholders%2C+and+Receipt+of+Final+Order/22916145.html for the full story. http://www.streetinsider.com/Accesswire/Tryp+Therapeutics+Announces+99.92%25+Votes+Cast+by+Shareholders+in+Favor+of+Arrangement+Agreement+at+Annual+General+and+Special+Meeting+of+Securityholders%2C+and+Receipt+of+Final+Order/22916145.html Tue, 12 Mar 2024 06:00:00 -0400 TRYPF http://www.streetinsider.com/Press+Releases/Tryp+Therapeutics+Obtains+Interim+Order+for+Plan+of+Arrangement+and+Provides+Details+of+Shareholder+Meeting/22742765.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Tryp+Therapeutics+Obtains+Interim+Order+for+Plan+of+Arrangement+and+Provides+Details+of+Shareholder+Meeting/22742765.html for the full story. http://www.streetinsider.com/Press+Releases/Tryp+Therapeutics+Obtains+Interim+Order+for+Plan+of+Arrangement+and+Provides+Details+of+Shareholder+Meeting/22742765.html Thu, 08 Feb 2024 16:00:00 -0400 TRYPF http://www.streetinsider.com/Accesswire/Tryp+Therapeutics+Obtains+Interim+Order+for+Plan+of+Arrangement+and+Provides+Details+of+Shareholder+Meeting/22742765.html Visit StreetInsider.com at http://www.streetinsider.com/Accesswire/Tryp+Therapeutics+Obtains+Interim+Order+for+Plan+of+Arrangement+and+Provides+Details+of+Shareholder+Meeting/22742765.html for the full story. http://www.streetinsider.com/Accesswire/Tryp+Therapeutics+Obtains+Interim+Order+for+Plan+of+Arrangement+and+Provides+Details+of+Shareholder+Meeting/22742765.html Thu, 08 Feb 2024 16:00:00 -0400 TRYPF http://www.streetinsider.com/Press+Releases/Tryp+Therapeutics+and+Exopharm+Limited+Secure+Pivotal+2+Cent+Waiver+From+ASX/22677614.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Tryp+Therapeutics+and+Exopharm+Limited+Secure+Pivotal+2+Cent+Waiver+From+ASX/22677614.html for the full story. http://www.streetinsider.com/Press+Releases/Tryp+Therapeutics+and+Exopharm+Limited+Secure+Pivotal+2+Cent+Waiver+From+ASX/22677614.html Fri, 26 Jan 2024 06:00:00 -0400 TRYPF http://www.streetinsider.com/Accesswire/Tryp+Therapeutics+and+Exopharm+Limited+Secure+Pivotal+2+Cent+Waiver+From+ASX/22677614.html Visit StreetInsider.com at http://www.streetinsider.com/Accesswire/Tryp+Therapeutics+and+Exopharm+Limited+Secure+Pivotal+2+Cent+Waiver+From+ASX/22677614.html for the full story. http://www.streetinsider.com/Accesswire/Tryp+Therapeutics+and+Exopharm+Limited+Secure+Pivotal+2+Cent+Waiver+From+ASX/22677614.html Fri, 26 Jan 2024 06:00:00 -0400 TRYPF http://www.streetinsider.com/Press+Releases/Tryp+Therapeutics+Announces+Significant+Milestone+in+Its+Clinical+Trial+Program+for+Trp-8803+%28IV-infused+Psilocin%29/22604547.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Tryp+Therapeutics+Announces+Significant+Milestone+in+Its+Clinical+Trial+Program+for+Trp-8803+%28IV-infused+Psilocin%29/22604547.html for the full story. http://www.streetinsider.com/Press+Releases/Tryp+Therapeutics+Announces+Significant+Milestone+in+Its+Clinical+Trial+Program+for+Trp-8803+%28IV-infused+Psilocin%29/22604547.html Mon, 08 Jan 2024 07:00:00 -0400 TRYPF http://www.streetinsider.com/Accesswire/Tryp+Therapeutics+Announces+Significant+Milestone+in+Its+Clinical+Trial+Program+for+Trp-8803+%28IV-infused+Psilocin%29/22604547.html Visit StreetInsider.com at http://www.streetinsider.com/Accesswire/Tryp+Therapeutics+Announces+Significant+Milestone+in+Its+Clinical+Trial+Program+for+Trp-8803+%28IV-infused+Psilocin%29/22604547.html for the full story. http://www.streetinsider.com/Accesswire/Tryp+Therapeutics+Announces+Significant+Milestone+in+Its+Clinical+Trial+Program+for+Trp-8803+%28IV-infused+Psilocin%29/22604547.html Mon, 08 Jan 2024 07:00:00 -0400 TRYPF http://www.streetinsider.com/Press+Releases/Tryp+Therapeutics+Announces+Jason+Carroll+as+New+Chief+Executive+Officer/21989475.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Tryp+Therapeutics+Announces+Jason+Carroll+as+New+Chief+Executive+Officer/21989475.html for the full story. http://www.streetinsider.com/Press+Releases/Tryp+Therapeutics+Announces+Jason+Carroll+as+New+Chief+Executive+Officer/21989475.html Thu, 03 Aug 2023 06:00:00 -0400 TRYPF http://www.streetinsider.com/Accesswire/Tryp+Therapeutics+Announces+Jason+Carroll+as+New+Chief+Executive+Officer/21989475.html Visit StreetInsider.com at http://www.streetinsider.com/Accesswire/Tryp+Therapeutics+Announces+Jason+Carroll+as+New+Chief+Executive+Officer/21989475.html for the full story. http://www.streetinsider.com/Accesswire/Tryp+Therapeutics+Announces+Jason+Carroll+as+New+Chief+Executive+Officer/21989475.html Thu, 03 Aug 2023 06:00:00 -0400 TRYPF http://www.streetinsider.com/Press+Releases/With+Great+Sadness+Tryp+Announces+the+Passing+of+David+Tousley%2C+Director/21981977.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/With+Great+Sadness+Tryp+Announces+the+Passing+of+David+Tousley%2C+Director/21981977.html for the full story. http://www.streetinsider.com/Press+Releases/With+Great+Sadness+Tryp+Announces+the+Passing+of+David+Tousley%2C+Director/21981977.html Wed, 02 Aug 2023 06:00:00 -0400 TRYPF http://www.streetinsider.com/Accesswire/With+Great+Sadness+Tryp+Announces+the+Passing+of+David+Tousley%2C+Director/21981977.html Visit StreetInsider.com at http://www.streetinsider.com/Accesswire/With+Great+Sadness+Tryp+Announces+the+Passing+of+David+Tousley%2C+Director/21981977.html for the full story. http://www.streetinsider.com/Accesswire/With+Great+Sadness+Tryp+Announces+the+Passing+of+David+Tousley%2C+Director/21981977.html Wed, 02 Aug 2023 06:00:00 -0400 TRYPF http://www.streetinsider.com/Press+Releases/Tryp+Therapeutics+Receives+Confirmation+From+FDA+To+Proceed+With+Phase+2A+Clinical+Trial+in+Patients+With+IBS+at+Massachusetts+General+Hospital/21903555.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Tryp+Therapeutics+Receives+Confirmation+From+FDA+To+Proceed+With+Phase+2A+Clinical+Trial+in+Patients+With+IBS+at+Massachusetts+General+Hospital/21903555.html for the full story. http://www.streetinsider.com/Press+Releases/Tryp+Therapeutics+Receives+Confirmation+From+FDA+To+Proceed+With+Phase+2A+Clinical+Trial+in+Patients+With+IBS+at+Massachusetts+General+Hospital/21903555.html Thu, 13 Jul 2023 06:00:00 -0400 TRYPF http://www.streetinsider.com/Accesswire/Tryp+Therapeutics+Receives+Confirmation+From+FDA+To+Proceed+With+Phase+2A+Clinical+Trial+in+Patients+With+IBS+at+Massachusetts+General+Hospital/21903555.html Visit StreetInsider.com at http://www.streetinsider.com/Accesswire/Tryp+Therapeutics+Receives+Confirmation+From+FDA+To+Proceed+With+Phase+2A+Clinical+Trial+in+Patients+With+IBS+at+Massachusetts+General+Hospital/21903555.html for the full story. http://www.streetinsider.com/Accesswire/Tryp+Therapeutics+Receives+Confirmation+From+FDA+To+Proceed+With+Phase+2A+Clinical+Trial+in+Patients+With+IBS+at+Massachusetts+General+Hospital/21903555.html Thu, 13 Jul 2023 06:00:00 -0400 TRYPF http://www.streetinsider.com/Press+Releases/Tryp+Therapeutics+Submits+Investigational+New+Drug+%28IND%29+Application+to+US+FDA+for+Planned+Phase+2a+Clinical+Trial+in+Patients+With+IBS+at+Massachusetts+General+Hospital/21708898.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Tryp+Therapeutics+Submits+Investigational+New+Drug+%28IND%29+Application+to+US+FDA+for+Planned+Phase+2a+Clinical+Trial+in+Patients+With+IBS+at+Massachusetts+General+Hospital/21708898.html for the full story. http://www.streetinsider.com/Press+Releases/Tryp+Therapeutics+Submits+Investigational+New+Drug+%28IND%29+Application+to+US+FDA+for+Planned+Phase+2a+Clinical+Trial+in+Patients+With+IBS+at+Massachusetts+General+Hospital/21708898.html Wed, 24 May 2023 06:00:00 -0400 TRYPF http://www.streetinsider.com/Accesswire/Tryp+Therapeutics+Submits+Investigational+New+Drug+%28IND%29+Application+to+US+FDA+for+Planned+Phase+2a+Clinical+Trial+in+Patients+With+IBS+at+Massachusetts+General+Hospital/21708898.html Visit StreetInsider.com at http://www.streetinsider.com/Accesswire/Tryp+Therapeutics+Submits+Investigational+New+Drug+%28IND%29+Application+to+US+FDA+for+Planned+Phase+2a+Clinical+Trial+in+Patients+With+IBS+at+Massachusetts+General+Hospital/21708898.html for the full story. http://www.streetinsider.com/Accesswire/Tryp+Therapeutics+Submits+Investigational+New+Drug+%28IND%29+Application+to+US+FDA+for+Planned+Phase+2a+Clinical+Trial+in+Patients+With+IBS+at+Massachusetts+General+Hospital/21708898.html Wed, 24 May 2023 06:00:00 -0400 TRYPF http://www.streetinsider.com/Press+Releases/Tryp+Therapeutics+Completes+Psychotherapy+Training+for+Planned+Phase+2a+Clinical+Trial+at+Massachusetts+General+Hospital/21461675.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Tryp+Therapeutics+Completes+Psychotherapy+Training+for+Planned+Phase+2a+Clinical+Trial+at+Massachusetts+General+Hospital/21461675.html for the full story. http://www.streetinsider.com/Press+Releases/Tryp+Therapeutics+Completes+Psychotherapy+Training+for+Planned+Phase+2a+Clinical+Trial+at+Massachusetts+General+Hospital/21461675.html Tue, 04 Apr 2023 06:00:00 -0400 TRYPF http://www.streetinsider.com/Accesswire/Tryp+Therapeutics+Completes+Psychotherapy+Training+for+Planned+Phase+2a+Clinical+Trial+at+Massachusetts+General+Hospital/21461675.html Visit StreetInsider.com at http://www.streetinsider.com/Accesswire/Tryp+Therapeutics+Completes+Psychotherapy+Training+for+Planned+Phase+2a+Clinical+Trial+at+Massachusetts+General+Hospital/21461675.html for the full story. http://www.streetinsider.com/Accesswire/Tryp+Therapeutics+Completes+Psychotherapy+Training+for+Planned+Phase+2a+Clinical+Trial+at+Massachusetts+General+Hospital/21461675.html Tue, 04 Apr 2023 06:00:00 -0400 TRYPF http://www.streetinsider.com/Press+Releases/Tryp+Therapeutics+Announces+Interim+Results+for+Its+Phase+II+Clinical+Trial+for+the+Treatment+of+Binge+Eating+Disorder+With+Psilocybin-Assisted+Psychotherapy/21036226.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Tryp+Therapeutics+Announces+Interim+Results+for+Its+Phase+II+Clinical+Trial+for+the+Treatment+of+Binge+Eating+Disorder+With+Psilocybin-Assisted+Psychotherapy/21036226.html for the full story. http://www.streetinsider.com/Press+Releases/Tryp+Therapeutics+Announces+Interim+Results+for+Its+Phase+II+Clinical+Trial+for+the+Treatment+of+Binge+Eating+Disorder+With+Psilocybin-Assisted+Psychotherapy/21036226.html Thu, 05 Jan 2023 07:00:00 -0400 TRYPF http://www.streetinsider.com/Accesswire/Tryp+Therapeutics+Announces+Interim+Results+for+Its+Phase+II+Clinical+Trial+for+the+Treatment+of+Binge+Eating+Disorder+With+Psilocybin-Assisted+Psychotherapy/21036226.html Visit StreetInsider.com at http://www.streetinsider.com/Accesswire/Tryp+Therapeutics+Announces+Interim+Results+for+Its+Phase+II+Clinical+Trial+for+the+Treatment+of+Binge+Eating+Disorder+With+Psilocybin-Assisted+Psychotherapy/21036226.html for the full story. http://www.streetinsider.com/Accesswire/Tryp+Therapeutics+Announces+Interim+Results+for+Its+Phase+II+Clinical+Trial+for+the+Treatment+of+Binge+Eating+Disorder+With+Psilocybin-Assisted+Psychotherapy/21036226.html Thu, 05 Jan 2023 07:00:00 -0400 TRYPF http://www.streetinsider.com/Press+Releases/Tryp+Therapeutics+and+Massachusetts+General+Hospital+Sign+Letter+of+Intent+for+Clinical+Study+Investigating+the+Use+of+Psilocybin-Assisted+Psychotherapy+for+the+Treatment+of+Patients+Suffering+From+Ir/21022308.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Tryp+Therapeutics+and+Massachusetts+General+Hospital+Sign+Letter+of+Intent+for+Clinical+Study+Investigating+the+Use+of+Psilocybin-Assisted+Psychotherapy+for+the+Treatment+of+Patients+Suffering+From+Ir/21022308.html for the full story. http://www.streetinsider.com/Press+Releases/Tryp+Therapeutics+and+Massachusetts+General+Hospital+Sign+Letter+of+Intent+for+Clinical+Study+Investigating+the+Use+of+Psilocybin-Assisted+Psychotherapy+for+the+Treatment+of+Patients+Suffering+From+Ir/21022308.html Tue, 03 Jan 2023 07:00:00 -0400 TRYPF http://www.streetinsider.com/Accesswire/Tryp+Therapeutics+and+Massachusetts+General+Hospital+Sign+Letter+of+Intent+for+Clinical+Study+Investigating+the+Use+of+Psilocybin-Assisted+Psychotherapy+for+the+Treatment+of+Patients+Suffering+From+Ir/21022308.html Visit StreetInsider.com at http://www.streetinsider.com/Accesswire/Tryp+Therapeutics+and+Massachusetts+General+Hospital+Sign+Letter+of+Intent+for+Clinical+Study+Investigating+the+Use+of+Psilocybin-Assisted+Psychotherapy+for+the+Treatment+of+Patients+Suffering+From+Ir/21022308.html for the full story. http://www.streetinsider.com/Accesswire/Tryp+Therapeutics+and+Massachusetts+General+Hospital+Sign+Letter+of+Intent+for+Clinical+Study+Investigating+the+Use+of+Psilocybin-Assisted+Psychotherapy+for+the+Treatment+of+Patients+Suffering+From+Ir/21022308.html Tue, 03 Jan 2023 07:00:00 -0400 TRYPF http://www.streetinsider.com/Press+Releases/Tryp+Therapeutics+to+Present+at+Biotech+Showcase+on+Monday%2C+January+9%2C+2023/20994757.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Tryp+Therapeutics+to+Present+at+Biotech+Showcase+on+Monday%2C+January+9%2C+2023/20994757.html for the full story. http://www.streetinsider.com/Press+Releases/Tryp+Therapeutics+to+Present+at+Biotech+Showcase+on+Monday%2C+January+9%2C+2023/20994757.html Wed, 21 Dec 2022 10:50:00 -0400 A.10141387 A.12763360 O.20319167 O.49935848 TRYP TRYPF